Indivior Pharmaceuticals, Inc. (INDV)
36.18
-0.69
(-1.87%)
USD |
NASDAQ |
Aug 24, 16:00
36.18
0.00 (0.00%)
After-Hours: 20:00
Indivior Pharmaceuticals Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 219.05 |
| June 27, 2024 | 222.59 |
| June 26, 2024 | 224.08 |
| June 25, 2024 | 221.23 |
| June 24, 2024 | 225.85 |
| June 21, 2024 | 228.16 |
| June 20, 2024 | 218.64 |
| June 18, 2024 | 215.52 |
| June 17, 2024 | 222.04 |
| June 14, 2024 | 224.62 |
| June 13, 2024 | 221.36 |
| June 12, 2024 | 228.97 |
| June 11, 2024 | 229.24 |
| June 10, 2024 | 230.60 |
| June 07, 2024 | 222.18 |
| June 06, 2024 | 228.56 |
| June 05, 2024 | 242.02 |
| June 04, 2024 | 245.55 |
| June 03, 2024 | 249.49 |
| May 31, 2024 | 248.95 |
| May 30, 2024 | 245.55 |
| May 29, 2024 | 245.14 |
| May 28, 2024 | 251.12 |
| May 24, 2024 | 236.04 |
| May 23, 2024 | 227.21 |
| Date | Value |
|---|---|
| May 22, 2024 | 227.75 |
| May 21, 2024 | 231.69 |
| May 20, 2024 | 232.23 |
| May 17, 2024 | 230.60 |
| May 16, 2024 | 235.63 |
| May 15, 2024 | 238.08 |
| May 14, 2024 | 238.21 |
| May 13, 2024 | 242.83 |
| May 10, 2024 | 240.93 |
| May 09, 2024 | 242.83 |
| May 08, 2024 | 241.61 |
| May 07, 2024 | 240.52 |
| May 06, 2024 | 246.64 |
| May 03, 2024 | 243.92 |
| May 02, 2024 | 243.65 |
| May 01, 2024 | 239.57 |
| April 30, 2024 | 238.62 |
| April 29, 2024 | 243.65 |
| April 26, 2024 | 238.89 |
| April 25, 2024 | 234.41 |
| April 24, 2024 | 255.61 |
| April 23, 2024 | 253.16 |
| April 22, 2024 | 251.94 |
| April 19, 2024 | 251.67 |
| April 18, 2024 | 254.93 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Supernus Pharmaceuticals, Inc. | 2.544 |
| Liquidia Corp. | 32.09 |
| Corcept Therapeutics, Inc. | 18.84 |
| Amneal Pharmaceuticals, Inc. | 171.92 |
| Prestige Consumer Healthcare, Inc. | 1.285 |
Price to Book Value Related Metrics
| PE Ratio | 12.85 |
| PS Ratio | 3.443 |
| PEG Ratio | 0.0558 |
| Price | 36.18 |
| Earnings Yield | 7.78% |
| Market Cap | 4.269B |
| PEGY Ratio | 0.0558 |
| Operating PE Ratio | 8.620 |
| Normalized PE Ratio | 10.14 |